The investigators planned to analyze the effect of Covid-19 fear and anxiety on the daily life, sleep quality and depression-anxiety levels of fibromyalgia patients.
Fibromyalgia; as a chronic syndrome of unknown cause with widespread body pain, fatigue,
sleep disorder, cognitive impairment and anxiety. Many studies have shown a relationship
between pain levels and anxiety levels in patients with fibromyalgia. Covid-19 started from
Wuhan, China in December 2019 and spread worldwide. The rapid spread of this unexpected
pandemic all over the world brought with it many conditions such as anxiety and stress
disorders. It has been reported by experts that individuals with a predisposition to
conditions such as anxiety and stress disorder in premorbidity require special attention.To
evaluate the psychological effects of the Covid-19 pandemic, the Covid-19 anxiety scale was
developed from Lee et al. and the Covid-19 fear scale was developed from Ahoursou et al. The
investigators planned to analyzed the effect on Covid-19 fear and anxiety level on
fibromyalgia patients' daily life with revised Fibromyalgia Impact questionnaire, sleep
quality with Pittsburgh Sleep Quality Index, and anxiety-depression level with The Hospital
Anxiety and Depression scale. This study was planned as a cross-sectional case control study.
Inclusion Criteria (Fibromyalgia group):
- Patients diagnosed as Fibromyalgia syndrome according to American College of
Rheumatology over 1 year
- Patients' disease activity is stabil at least 3 months Inclusion Criteria (Control
group) Patients have no physicologic or severe musculoskeletal and rheumatologic
diseases
Exclusion Criteria:
- Patients with having other modd disorders
- Patients with severe musculoskeletal diseases
- Patients with other rheumatologic diseases
Diskapi Education and Research Hospital
Ankara, Altındag, Turkey
Investigator: Damla Cankurtaran, MD
Contact: +903125962994
damlacengizftr@gmail.com
Damla Cankurtaran, MD
+905054558101
damlacengizftr@gmail.com